ID: h-851ef04ad8
Hypothesis
Dendritic tau missorting persists through local proteostatic failure in endolysosomal and autophagy pathways
Mislocalized tau impairs dendritic endosome-lysosome and autophagy flux, trapping tau species in the somatodendritic compartment and sustaining synaptotoxic signaling after Aβ has been removed.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 4 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
Mislocalized tau impairs dendritic endosome-lysosome and autophagy flux, trapping tau species in the somatodendritic compartment and sustaining synaptotoxic signaling after Aβ has been removed. This is best viewed as a persistence amplifier rather than the leading initiating mechanism.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["MAPT/Tau Protein<br/>Microtubule Stabilizer"]
B["CDK5/GSK3B Activation<br/>Kinase Dysregulation"]
C["Tau Hyperphosphorylation<br/>Ser396/Thr231/Ser202"]
D["Tau Detachment<br/>Microtubule Destabilized"]
E["Tau Oligomers<br/>Paired Helical Filaments"]
F["Neurofibrillary Tangles<br/>Intraneuronal Inclusions"]
G["Axonal Transport Failure<br/>Synaptic Dysfunction"]
H["Neurodegeneration<br/>Tauopathy Spread"]
A --> B
B --> C
C --> D
D --> E
E --> F
D --> G
G --> H
F --> H
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style C fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix4 supports2 contradicts
Supports
Tau accumulation and neuritic proteostasis defects are common in AD-relevant systems, supporting a potential maintenance role.
Supports
Aβ-induced tau missorting provides a plausible upstream insult that could overload local clearance machinery.
Supports
BAG3 and SYNPO (synaptopodin) facilitate phospho-MAPT/Tau degradation via autophagy in neuronal processes.
Supports
The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD).
Contradicts
Direct evidence that transient Aβ exposure alone creates a durable dendrite-localized clearance defect sufficient to maintain missorting is limited.
Contradicts
Autophagy-enhancing interventions are highly nonspecific, so positive rescue would not uniquely validate this mechanism.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — MAPT
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for MAPT,RAB5,RAB7,LAMP1,TFEB from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for MAPT,RAB5,RAB7,LAMP1,TFEB.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0079
Events (7d)
1
Price History
▼0.1%💾 Resource Usage
LLM Tokens
17,362
$0.0521
Total Cost
$0.0521
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF early-life Aβ pathology is pharmacologically cleared (via anti-Aβ antibody or BACE inhibitor) in 5xFAD mice but somatodendritic RAB7 and LAMP1 activity remains impaired, THEN phosphorylated tau acc | Sustained dendritic tau accumulation despite Aβ removal | — no observation — | pending | 0.55 |
| IF TFEB is selectively overexpressed in primary neurons from hMAPT transgenic mice to enhance endolysosomal and autophagy flux in the somatodendritic compartment, THEN dendritic tau mislocalization (m | Reduced somatodendritic tau accumulation with restored synaptic protein levels | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF TFEB is selectively overexpressed in primary neurons from hMAPT transgenic mice to enhance endolysosomal and autophagy flux in the somatodendritic compartment, THEN dendritic tau mislocalization (measured by dendritic/somatic tau ratio via confocal microscopy) will decrease by ≥30% AND synaptic m
Predicted outcome: Reduced somatodendritic tau accumulation with restored synaptic protein levels
Falsification: Dendritic tau ratio remains unchanged (<10% change) OR synaptic markers show no improvement (<10% change) despite successful TFEB nuclear translocation confirmed by immunocytochemistry
pendingconf 55%
IF early-life Aβ pathology is pharmacologically cleared (via anti-Aβ antibody or BACE inhibitor) in 5xFAD mice but somatodendritic RAB7 and LAMP1 activity remains impaired, THEN phosphorylated tau accumulation at dendritic spines (p-tau S396/S404 measured by PLA and super-resolution microscopy) will
Predicted outcome: Sustained dendritic tau accumulation despite Aβ removal
Falsification: Phosphorylated dendritic tau decreases by >40% following Aβ clearance, indicating Aβ rather than tau missorting is the primary driver of dendritic pathology
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.